Cargando…

Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer

Detalles Bibliográficos
Autores principales:	Lynn, Rachel C, Matsuyama, Takami, Powell, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646120/ http://dx.doi.org/10.1186/2051-1426-3-S2-P32

Ejemplares similares

Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1
por: Samaniego, Rafael, et al.
Publicado: (2020)

High affinity FRβ-specific CAR T cells eradicate AML and normal yeloid lineage without HSC toxicity
por: Lynn, Rachel C, et al.
Publicado: (2016)

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021)

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
por: Ao, Xiang, et al.
Publicado: (2019)

Enhancing T cell persistence of CAR-redirected T cells in solid tumors
por: Guedan, Sonia, et al.
Publicado: (2014)

On-target off-tumor toxicity; when enhancing an NKG2D-based CAR in vitro led to severe toxicities in vivo
por: VanSeggelen, Heather, et al.
Publicado: (2014)

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)
por: Walker, Alec, et al.
Publicado: (2014)

Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013)

Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
por: Smith, Jenessa B, et al.
Publicado: (2015)

Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015)

Modifying tumor associated macrophage function through cannabinoid receptor 2
por: Arabatzis, Taxiarhia, et al.
Publicado: (2015)

Chimeric antigen receptors (CARs) incorporating mutations in the IgG4 Fc spacer region to eliminate Fc receptor recognition results in improved CAR T cell persistence and anti-tumor efficacy
por: Jonnalagadda, Mahesh, et al.
Publicado: (2013)

Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer
por: Schalper, Kurt Alex, et al.
Publicado: (2015)

Evaluation of FR104, a Treg sparing antagonist anti-CD28 monovalent Fab’ antibody in kidney transplantation in non-human primates
por: Poirier, Nicolas, et al.
Publicado: (2012)

A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target
por: Santoro, Stephen P, et al.
Publicado: (2013)

Single cell metrics of the efficacy of CAR T cells
por: Romain, Gabrielle, et al.
Publicado: (2015)

Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2013)

ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
por: Orentas, Rimas J, et al.
Publicado: (2013)

Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion
por: Jacoby, Elad, et al.
Publicado: (2015)

Precocious puberty and ovarian tumors – 2 case reports
por: Ramkumar, S, et al.
Publicado: (2013)

MR imaging of human atherosclerosis using immunomicelles molecularly targeted to macrophages
por: Amirbekian, Vardan, et al.
Publicado: (2009)

Quantitative single-cell characterization of CAR+ T cell effector functions
por: Liadi, Ivan, et al.
Publicado: (2013)

Functional and molecular characterization of single serial killer CAR+ T cells demonstrates adaptive modification of behavior and fate based on tumor cell density
por: Varadarajan, Navin, et al.
Publicado: (2014)

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
por: Park, Anthony K, et al.
Publicado: (2015)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Deletion of NF-kB p50 alters murine glioblastoma tumor-associated macrophage polarization, reduces tumor growth and prolongs survival
por: Barberi, Theresa, et al.
Publicado: (2015)

Go-CART: an animal-free system for the assessment of CAR T cell function
por: Bajgain, Pradip, et al.
Publicado: (2015)

Immunosuppression through HNF-1β signaling in human ovarian clear cell cancer
por: Nishio, Hiroshi, et al.
Publicado: (2013)

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity
por: Huang, Xianming, et al.
Publicado: (2013)

Complementary cooperation of an ambulance helicopter and car with medical doctors: meaning of simultaneous dispatch
por: Ishii, K, et al.
Publicado: (2014)

Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
por: Rushworth, David, et al.
Publicado: (2013)

Targeting the TGFβ pathway with galunisertib, a TGFβRI SMI, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint inhibition
por: Schaer, David, et al.
Publicado: (2015)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Macrophage-fibroblast interplay: a target for neuropeptide-based treatment of fibrotic disease?
por: Virakul, Sita, et al.
Publicado: (2012)

Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
por: Gerdts, Ethan, et al.
Publicado: (2015)

TEM8 specific T cells target the tumor cells and tumor-associated vasculature in triple negative breast cancer
por: Byrd, Tiara, et al.
Publicado: (2014)

Differential expression of cytoplasmic and stromal β-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
por: Lundgren, K, et al.
Publicado: (2009)

The impact of β-adrenergic signaling on radioresistance and anti-tumor immunity
por: Bucsek, Mark, et al.
Publicado: (2015)

MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy
por: Mata, Melinda, et al.
Publicado: (2015)

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
por: Mannioui, Cécile Schiffer, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_22f6ve79lgs7fviag8fcl404r4